US 8,185,954

Application 11/915,125 · Granted May 22, 2012

Resisting the spread of unwanted code and data

Estimated expiration

January 24, 2029

2y 64d remaining

Confidence: high
High: no high-severity warning was raised, and any terminal disclaimer was resolved to the patents it references.
  • Could not fetch continuity data for application PCTGB2006002107: Resource not found (404)
Earliest effective filing
Jun 9, 2006
+ 20 years
Jun 9, 2026
PTA +960d
Jan 24, 2029
No TD
—
Final
Jan 24, 2029

This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included.

Calculation details

Base term

Filing date
June 17, 2008
Earliest effective filing
June 9, 2006
Issue date
May 22, 2012
PTA
+960 days
Base expiry (before PTA)
June 9, 2026

June 9, 2006 + 20 years = June 9, 2026 + 960 PTA days = January 24, 2029

  • National stage entry of application PCTGB2006002107, filed Jun 9, 2006

Terminal disclaimers

No TD0 approved, 0 filed

Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated

You have the date. Your AI can have the file.

Application 11/915,125 · US 8,185,954

PatentReply compiles the prosecution history behind US 8,185,954: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.

One new published application a month is free. The first compile takes a few minutes.

Strategy and filing changes require your approval.

How PatentReply handles an Office Action response →

Permanent link

www.patentreply.ai/tools/patent-expiration/US8185954

Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.